Impact of a protein-based assay that predicts prostate cancer aggressiveness on urologists’ recommendations for active treatment or active surveillance: a randomized clinical utility trial

BACKGROUND: Of the more than 1.1 million men diagnosed worldwide annually with prostate cancer, the majority have indolent tumors. Distinguishing between aggressive and indolent cancer is an important clinical challenge. The current approaches for assessing tumor aggressiveness are recognized as ins...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Urol
Main Authors: Peabody, John W., DeMaria, Lisa M., Tamondong-Lachica, Diana, Florentino, Jhiedon, Czarina Acelajado, M., Ouenes, Othman, Richie, Jerome P., Burgon, Trever
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5496184/
https://ncbi.nlm.nih.gov/pubmed/28673277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-017-0243-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados